MET

Research material, Tryptamine, Classic Psychedelic

MET

Experience

👥 No personal reports yet

⚕ No clinical reports yet

Log in to add your own experience.

Problems

No problems yet. Be the first to suggest one.

+ Add a problem

Titration strategies

Multi-route dose ladders (Erowid, very tentative)▲0▼×

Erowid's dosage documentation for MET is marked "very tentative" by Erowid,

given limited reports. The following tiers are reported:

Oral:

• Light: 60-120 mg; Common: 80-150 mg; Strong: 150+ mg
• (Threshold not characterized; timing not provided)

Vaporized:

• Threshold: ~8 mg; Light: 10-20 mg; Common: 15-30 mg; Strong: 30-40+ mg

Insufflated:

• Light: 10-20 mg; Common: 15-25 mg

Intramuscular:

• Common: 10-30 mg; Strong: 30-50+ mg

The wide disparity between oral (60+ mg) and vaporized (8+ mg) tiers is a pharmacokinetic feature of the tryptamine class generally, and is particularly marked for MET. Erowid's own tentative qualification

should be reflected in any presentation of these figures.

+ Add a titration strategy

Effects

No effects listed yet. Be the first to suggest one.

+ Add an effect

Interactions

No interactions reported yet.

+ Add an interaction

Relevant anecdote

No anecdotes yet. Share a relevant one.

+ Add an anecdote

Relevant Literature

No literature entries yet.

Log in to submit relevant literature.

Summary

Classes

Research material, Tryptamine, Classic Psychedelic

Common uses

Pharmacy

Pharmacology

Purported mechanism

5-HT2A agonist